Company Profile
Chemboxer Science and Technology Co., Ltd. is an innovative biomedical company with independent research and development capacities. It conducts high-level biochemical synthesis with a series of its own intellectual property rights. Our company follows closely the industry trend, and the latest research achievements in life science area. Our main focus is to provide chemical custom synthesis services,and as well the high added-value medicine intermediate and drug development. We can provide premium tailor-made products to fit each customer need which ranging from grams to kilograms, by utilizing our highly efficient production process and our professional team. Our vision is to help the global customers to shorten their drug development cycle and reduce development cost through our excellent quality and highly efficient outsourcing service. More than 8 years experience in providing custom synthesis in our laboratories. We work diligently to make every possible chemical to meet the needs of our customers. What this means is that you can purchase many other products than the ones you found on our website. We will create custom-made products for you. The new product will satisfy your requirements. In our laboratories, we are able to carry out different types of synthesis which includes multistage synthesis. This allows us to develop more complex solutions for your needs. All you need to do if you need custom synthesis is to provide us with the parameters you require including CAS number, name, and quantity of the product. We will then develop the proper synthesis program, complete all necessary research and synthesis the product. All products will undergo strict quality test with the full QC analysis, including NMR, LC-MS, HPLC, and Chiral HPLC. Chemboxer chemicals are of high purity, typically over 98% by HPLC, and the bioactivity is also approved. Chemboxer has Satisfaction Guarantee return policy. Your research is very important to us and your satisfaction is our top priority.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
ABT-199, GDC-0199 |
Benzamide,4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-;4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;ABT 199;GDC 0199;Venetoclax;Venclexta;Venclyxto;RG 7601;RG7601;RG-7601 |
1257044-40-8 | Inquiry | |
ABT-737 |
Benzamide,4-[4-[(4′-chloro[1,1′-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]-;4-[4-[(4′-Chloro[1,1′-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide;ABT 737 |
852808-04-9 | Inquiry | |
Afatinib Dimaleate, BIBW2992 Dimaleate |
2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-,(2E)-,(2Z)-2-butenedioate (1:2);Afatinib dimaleate;BIBW 2992MA2;2047333-62-8 |
850140-73-7 | Inquiry | |
AGI-5198, IDH-C35 |
N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide;AGI5198;IDH-C35 /IDHC35;IDH C35;IDH-C35;N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide;1H-Imidazole-1-acetamide, N-[2-(cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-;N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide AGI 5198 |
1355326-35-0 | Inquiry | |
Aliskiren Hemifumarate, CGP 60536 |
Benzeneoctanamide,δ-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-,(αS,γS,δS,ζS)-,(2E)-2-butenedioate (2:1);Benzeneoctanamide,δ-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-,[αS-(αR*,γR*,δR*,ζR*)]-,(E)-2-butenedioate (2:1) (salt);Benzeneoctanamide,δ-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-,(αS,γS,δS,ζS)-,(2E)-2-butenedioate (2:1) (salt);Aliskiren hemifumarate;Aliskiren fumarate |
173334-58-2 | Inquiry | |
AP26113 |
2,4-Pyrimidinediamine,5-chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-;5-Chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-2,4-pyrimidinediamine |
1197958-12-5 | Inquiry | |
Aprepitant, MK-0869, L-754030 |
3H-1,2,4-Triazol-3-one,5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-;3H-1,2,4-Triazol-3-one,5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-,[2R-[2α(R*),3α]]-;5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one;L 754030;MK 869;Aprepitant;MK 0869;Emend;ONO 7436;221350-96-5 |
170729-80-3 | Inquiry | |
Aripiprazole, OPC-14597 |
2(1H)-Quinolinone,7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-;7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone;OPC 14597;Aripiprazole;OPC 31;7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril;Abilitat;Abilify;Arpizol;Asprito;Pripiprazole;Aripiperazole;Aripirazole;Aripiprazol;Aristab;Biopiprazole;AZ 1;AZ 2;AZ 3;AZ 4;156680-99-8 |
129722-12-9 | Inquiry | |
Atazanavir Sulfate, BMS-232632 |
2,5,6,10,13-Pentaazatetradecanedioic acid,3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-,1,14-dimethyl ester,(3S,8S,9S,12S)-,sulfate (1:1);2,5,6,10,13-Pentaazatetradecanedioic acid,3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-,dimethyl ester,(3S,8S,9S,12S)-,sulfate (1:1) (salt);Atazanavir sulfate;Atazor;Reyataz |
229975-97-7 | Inquiry | |
Axitinib, AG 013736 |
Benzamide,N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-;N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide;AG 013736;Axitinib;Inlyta;790713-39-2 |
319460-85-0 | Inquiry | |
AZD9291 |
2-Propenamide,N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-;N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide;AZD 9291;Osimertinib;Tagrisso;1610419-47-0 |
1421373-65-0 | Inquiry | |
BKM120, NVP-BKM120, Buparlisib |
2-Pyridinamine,5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-;5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine;BKM 120;NVP-BKM 120;Buparlisib;BKM 120NX;5-(2,6-Dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridine-2-amine;1202777-78-3 |
944396-07-0 | Inquiry | |
Bortezomib, PS-341, LDP-341, MLM341 |
Boronic acid,B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Boronic acid,[3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-,[S-(R*,S*)]-;Boronic acid,[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-;B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid;PS 341;PS 341 (pharmaceutical);MG 341;LDP 341;Bortezomib;MLN 341;Velcade;NSC 681239;DPBA;Radiciol;PS 314;Brotezamide;197730-97-5 |
179324-69-7 | Inquiry | |
Brinzolamide, AL-4862 |
2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide,4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-,1,1-dioxide,(4R)-;2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide,4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-,1,1-dioxide,(R)-;AL 4862;Brinzolamide;(5R)-5-Ethylamino-3-(3-methoxypropyl)-2,2-dioxo-2λ6,9-dithia-3-azabicyclo[4.3.0]nona-7,10-diene-8-sulfonamide;153191-05-0 |
138890-62-7 | Inquiry | |
Cabotegravir, GSK744, GSK1265744 |
Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide,N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-,(3S,11aR)-;(3S,11aR)-N-[(2,4-Difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide;Cabotegravir;GSK 1265744A;GSK 744;(3s,11Ar)-n-(2,4-difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide;1229006-15-8;2316731-82-3 |
1051375-10-0 | Inquiry | |
Cabozantinib malate, XL184 malate |
Butanedioic acid,2-hydroxy-,(2S)-,compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N′-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1);XL 184;Cabozantinib S-malate;Cometriq;(2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N′-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1);942407-59-2 |
1140909-48-3 | Inquiry | |
Cabozantinib, XL184, BMS-907351 |
1,1-Cyclopropanedicarboxamide,N′-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-;1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N′-(4-fluorophenyl)-;N′-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;Cabozantinib;BMS 907351;Cabometyx;1-N-[4-(6,7-Dimethoxyquinolin-4-yl)oxyphenyl]-1-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;XL 184 |
849217-68-1 | Inquiry | |
CAL-101, Idelalisib, GS-1101 |
4(3H)-Quinazolinone,5-fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-;4(3H)-Quinazolinone,5-fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]-;5-Fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-4(3H)-quinazolinone;CAL 101;GS 1101;Idelalisib;Zydelig;N6-[(S)-1-(5-Fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl]adenine;Delalisib;(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one |
870281-82-6 | Inquiry | |
Canagliflozin, TA 7284, JNJ 28431754 |
D-Glucitol,1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-,(1S)-;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;TA 7284;JNJ 28431754;Canagliflozin;JNJ 28431754AAA;JNJ 24831754ZAE;Invokana;1-(β-D-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;2169850-08-0 |
842133-18-0 | Inquiry | |
Capmatinib, INCB28060, INC280, NVP-INC280 |
Benzamide,2-fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]-;2-Fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide;2-Fluoro-N-methyl-4-[7-[(quinolin-6-yl)methyl]imidazo[1,2-b]-[1,2,4]triazin-2-yl]benzamide;INCB 28060;Capmatinib;INC 280;NVP-INC 280NX;Tabrecta;1362837-07-7 |
1029712-80-8 | Inquiry |
CONTACT INFORMATION
Sign In for Details